KARRI TRIVETT: Open Payments
NPI 1699249060 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 31 payments from 15 companies in 2025. Trend: 2023 $1,540 · 2024 $1,524 · 2025 $621
Food & beverage: $576Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $93 |
| Lilly USA, LLC | 3 | $84 |
| ABBVIE INC. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Amgen Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Ossur Americas, Inc. | 1 | $26 |
Products named: REXULTI, TRELEGY ELLIPTA, XIFAXAN, QULIPTA, Ozempic, JARDIANCE, ELIQUIS, The Cologuard Plus Collection Kit.
Industry payments across TN — which companies pay providers there.
